Global Biologics and Biosimilars Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Feb, 2020
|
Report ID: 117027
|
139
|
Pharmaceuticals and Healthcare
Summary
Market Overview
The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 279640 million by 2025, from USD 236240 million in 2019.
The Biologics and Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biologics and Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biologics and Biosimilars
market has been segmented into Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other, etc.
By Application, Biologics and Biosimilars has been segmented into Tumor, Diabetes, Cardiovascular, Hemophilia, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologics and Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologics and Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologics and Biosimilars market.
The report offers in-depth assessment of the growth and other aspects of the Biologics and Biosimilars market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Biologics and Biosimilars markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Biologics and Biosimilars Market Share Analysis
Biologics and Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biologics and Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologics and Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Biologics and Biosimilars are: Roche, Eli Lilly, Sanofi-Aventis, Amgen, Novo Nordisk, AbbVie, Merck, Pfizer, Johnson & Johnson, Novartis, Gelgen, Ganlee, 3sbio, Innovent, Biotech, Changchun High Tech, Dong Bao, CP Guojian, etc. Among other players domestic and global, Biologics and Biosimilars market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars in 2018 and 2019.
Chapter 3, the Biologics and Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics and Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Market Overview
The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 279640 million by 2025, from USD 236240 million in 2019.
The Biologics and Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biologics and Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biologics and Biosimilars
market has been segmented into Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other, etc.
By Application, Biologics and Biosimilars has been segmented into Tumor, Diabetes, Cardiovascular, Hemophilia, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologics and Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologics and Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologics and Biosimilars market.
The report offers in-depth assessment of the growth and other aspects of the Biologics and Biosimilars market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Biologics and Biosimilars markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Biologics and Biosimilars Market Share Analysis
Biologics and Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biologics and Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologics and Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Biologics and Biosimilars are: Roche, Eli Lilly, Sanofi-Aventis, Amgen, Novo Nordisk, AbbVie, Merck, Pfizer, Johnson & Johnson, Novartis, Gelgen, Ganlee, 3sbio, Innovent, Biotech, Changchun High Tech, Dong Bao, CP Guojian, etc. Among other players domestic and global, Biologics and Biosimilars market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars in 2018 and 2019.
Chapter 3, the Biologics and Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics and Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biologics and Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologics and Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologics and Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Overview of Global Biologics and Biosimilars Market
1.4.1 Global Biologics and Biosimilars Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi-Aventis SWOT Analysis
2.3.4 Sanofi-Aventis Product and Services
2.3.5 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novo Nordisk SWOT Analysis
2.5.4 Novo Nordisk Product and Services
2.5.5 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AbbVie SWOT Analysis
2.6.4 AbbVie Product and Services
2.6.5 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis SWOT Analysis
2.10.4 Novartis Product and Services
2.10.5 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Gelgen
2.11.1 Gelgen Details
2.11.2 Gelgen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Gelgen SWOT Analysis
2.11.4 Gelgen Product and Services
2.11.5 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ganlee
2.12.1 Ganlee Details
2.12.2 Ganlee Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ganlee SWOT Analysis
2.12.4 Ganlee Product and Services
2.12.5 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 3sbio
2.13.1 3sbio Details
2.13.2 3sbio Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 3sbio SWOT Analysis
2.13.4 3sbio Product and Services
2.13.5 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Innovent
2.14.1 Innovent Details
2.14.2 Innovent Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Innovent SWOT Analysis
2.14.4 Innovent Product and Services
2.14.5 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biotech
2.15.1 Biotech Details
2.15.2 Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Biotech SWOT Analysis
2.15.4 Biotech Product and Services
2.15.5 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Changchun High Tech
2.16.1 Changchun High Tech Details
2.16.2 Changchun High Tech Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Changchun High Tech SWOT Analysis
2.16.4 Changchun High Tech Product and Services
2.16.5 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Dong Bao
2.17.1 Dong Bao Details
2.17.2 Dong Bao Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Dong Bao SWOT Analysis
2.17.4 Dong Bao Product and Services
2.17.5 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 CP Guojian
2.18.1 CP Guojian Details
2.18.2 CP Guojian Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 CP Guojian SWOT Analysis
2.18.4 CP Guojian Product and Services
2.18.5 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020)
4.2 North America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.3 Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.5 South America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Country
5.1.1 North America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 United States Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5.3 Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5.4 Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Country
6.1.1 Europe Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
6.2 Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.3 UK Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.4 France Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.5 Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.6 Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020)
7.2 China Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.3 Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.4 Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.5 India Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.7 Australia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Country
8.1.1 South America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
8.1.2 South America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020)
8.3 Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biologics and Biosimilars Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.3 Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.4 Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biologics and Biosimilars Sales and Market Share by Type (2015-2020)
10.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2015-2020)
10.3 Global Biologics and Biosimilars Price by Type (2015-2020)
11 Global Biologics and Biosimilars Market Segment by Application
11.1 Global Biologics and Biosimilars Sales Market Share by Application (2015-2020)
11.2 Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020)
11.3 Global Biologics and Biosimilars Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2021-2025)
12.2 Biologics and Biosimilars Market Forecast by Regions (2021-2025)
12.2.1 North America Biologics and Biosimilars Market Forecast (2021-2025)
12.2.2 Europe Biologics and Biosimilars Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2021-2025)
12.2.4 South America Biologics and Biosimilars Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biologics and Biosimilars Market Forecast (2021-2025)
12.3 Biologics and Biosimilars Market Forecast by Type (2021-2025)
12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2025)
12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025)
12.4 Biologics and Biosimilars Market Forecast by Application (2021-2025)
12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2025)
12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
1 Market Overview
1.1 Biologics and Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologics and Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologics and Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Overview of Global Biologics and Biosimilars Market
1.4.1 Global Biologics and Biosimilars Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi-Aventis SWOT Analysis
2.3.4 Sanofi-Aventis Product and Services
2.3.5 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novo Nordisk SWOT Analysis
2.5.4 Novo Nordisk Product and Services
2.5.5 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AbbVie SWOT Analysis
2.6.4 AbbVie Product and Services
2.6.5 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis SWOT Analysis
2.10.4 Novartis Product and Services
2.10.5 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Gelgen
2.11.1 Gelgen Details
2.11.2 Gelgen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Gelgen SWOT Analysis
2.11.4 Gelgen Product and Services
2.11.5 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ganlee
2.12.1 Ganlee Details
2.12.2 Ganlee Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ganlee SWOT Analysis
2.12.4 Ganlee Product and Services
2.12.5 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 3sbio
2.13.1 3sbio Details
2.13.2 3sbio Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 3sbio SWOT Analysis
2.13.4 3sbio Product and Services
2.13.5 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Innovent
2.14.1 Innovent Details
2.14.2 Innovent Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Innovent SWOT Analysis
2.14.4 Innovent Product and Services
2.14.5 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biotech
2.15.1 Biotech Details
2.15.2 Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Biotech SWOT Analysis
2.15.4 Biotech Product and Services
2.15.5 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Changchun High Tech
2.16.1 Changchun High Tech Details
2.16.2 Changchun High Tech Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Changchun High Tech SWOT Analysis
2.16.4 Changchun High Tech Product and Services
2.16.5 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Dong Bao
2.17.1 Dong Bao Details
2.17.2 Dong Bao Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Dong Bao SWOT Analysis
2.17.4 Dong Bao Product and Services
2.17.5 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 CP Guojian
2.18.1 CP Guojian Details
2.18.2 CP Guojian Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 CP Guojian SWOT Analysis
2.18.4 CP Guojian Product and Services
2.18.5 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020)
4.2 North America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.3 Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.5 South America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Country
5.1.1 North America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 United States Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5.3 Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5.4 Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Country
6.1.1 Europe Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
6.2 Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.3 UK Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.4 France Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.5 Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.6 Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020)
7.2 China Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.3 Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.4 Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.5 India Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.7 Australia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Country
8.1.1 South America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
8.1.2 South America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020)
8.3 Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biologics and Biosimilars Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.3 Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.4 Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biologics and Biosimilars Sales and Market Share by Type (2015-2020)
10.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2015-2020)
10.3 Global Biologics and Biosimilars Price by Type (2015-2020)
11 Global Biologics and Biosimilars Market Segment by Application
11.1 Global Biologics and Biosimilars Sales Market Share by Application (2015-2020)
11.2 Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020)
11.3 Global Biologics and Biosimilars Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2021-2025)
12.2 Biologics and Biosimilars Market Forecast by Regions (2021-2025)
12.2.1 North America Biologics and Biosimilars Market Forecast (2021-2025)
12.2.2 Europe Biologics and Biosimilars Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2021-2025)
12.2.4 South America Biologics and Biosimilars Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biologics and Biosimilars Market Forecast (2021-2025)
12.3 Biologics and Biosimilars Market Forecast by Type (2021-2025)
12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2025)
12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025)
12.4 Biologics and Biosimilars Market Forecast by Application (2021-2025)
12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2025)
12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Biologics and Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biologics and Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Biologics and Biosimilars Major Business
Table 9. Roche Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 10. Roche SWOT Analysis
Table 11. Roche Biologics and Biosimilars Product and Services
Table 12. Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly Biologics and Biosimilars Major Business
Table 15. Eli Lilly Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 16. Eli Lilly SWOT Analysis
Table 17. Eli Lilly Biologics and Biosimilars Product and Services
Table 18. Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi-Aventis Biologics and Biosimilars Major Business
Table 21. Sanofi-Aventis Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 22. Sanofi-Aventis SWOT Analysis
Table 23. Sanofi-Aventis Biologics and Biosimilars Product and Services
Table 24. Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Amgen Basic Information, Manufacturing Base and Competitors
Table 26. Amgen Biologics and Biosimilars Major Business
Table 27. Amgen Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 28. Amgen SWOT Analysis
Table 29. Amgen Biologics and Biosimilars Product and Services
Table 30. Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 32. Novo Nordisk Biologics and Biosimilars Major Business
Table 33. Novo Nordisk Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 34. Novo Nordisk SWOT Analysis
Table 35. Novo Nordisk Biologics and Biosimilars Product and Services
Table 36. Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AbbVie Basic Information, Manufacturing Base and Competitors
Table 38. AbbVie Biologics and Biosimilars Major Business
Table 39. AbbVie Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 40. AbbVie SWOT Analysis
Table 41. AbbVie Biologics and Biosimilars Product and Services
Table 42. AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Biologics and Biosimilars Major Business
Table 45. Merck Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 46. Merck SWOT Analysis
Table 47. Merck Biologics and Biosimilars Product and Services
Table 48. Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Pfizer Basic Information, Manufacturing Base and Competitors
Table 50. Pfizer Biologics and Biosimilars Major Business
Table 51. Pfizer Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 52. Pfizer SWOT Analysis
Table 53. Pfizer Biologics and Biosimilars Product and Services
Table 54. Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 56. Johnson & Johnson Biologics and Biosimilars Major Business
Table 57. Johnson & Johnson Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 58. Johnson & Johnson SWOT Analysis
Table 59. Johnson & Johnson Biologics and Biosimilars Product and Services
Table 60. Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Biologics and Biosimilars Major Business
Table 63. Novartis Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 64. Novartis SWOT Analysis
Table 65. Novartis Biologics and Biosimilars Product and Services
Table 66. Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Gelgen Basic Information, Manufacturing Base and Competitors
Table 68. Gelgen Biologics and Biosimilars Major Business
Table 69. Gelgen Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 70. Gelgen SWOT Analysis
Table 71. Gelgen Biologics and Biosimilars Product and Services
Table 72. Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Ganlee Basic Information, Manufacturing Base and Competitors
Table 74. Ganlee Biologics and Biosimilars Major Business
Table 75. Ganlee Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 76. Ganlee SWOT Analysis
Table 77. Ganlee Biologics and Biosimilars Product and Services
Table 78. Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. 3sbio Basic Information, Manufacturing Base and Competitors
Table 80. 3sbio Biologics and Biosimilars Major Business
Table 81. 3sbio Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 82. 3sbio SWOT Analysis
Table 83. 3sbio Biologics and Biosimilars Product and Services
Table 84. 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Innovent Basic Information, Manufacturing Base and Competitors
Table 86. Innovent Biologics and Biosimilars Major Business
Table 87. Innovent Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 88. Innovent SWOT Analysis
Table 89. Innovent Biologics and Biosimilars Product and Services
Table 90. Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Biotech Biologics and Biosimilars Major Business
Table 93. Biotech Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 94. Biotech SWOT Analysis
Table 95. Biotech Biologics and Biosimilars Product and Services
Table 96. Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 98. Changchun High Tech Biologics and Biosimilars Major Business
Table 99. Changchun High Tech Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 100. Changchun High Tech SWOT Analysis
Table 101. Changchun High Tech Biologics and Biosimilars Product and Services
Table 102. Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Dong Bao Basic Information, Manufacturing Base and Competitors
Table 104. Dong Bao Biologics and Biosimilars Major Business
Table 105. Dong Bao Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 106. Dong Bao SWOT Analysis
Table 107. Dong Bao Biologics and Biosimilars Product and Services
Table 108. Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. CP Guojian Biologics and Biosimilars Type and Application
Table 110. CP Guojian Biologics and Biosimilars Major Business
Table 111. CP Guojian Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 112. CP Guojian SWOT Analysis
Table 113. CP Guojian Biologics and Biosimilars Product and Services
Table 114. CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Biologics and Biosimilars Sales by Manufacturer (2018-2019) (K Units)
Table 116. Global Biologics and Biosimilars Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Biologics and Biosimilars Sales by Regions (2015-2020) (K Units)
Table 118. Global Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Table 119. Global Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 121. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 122. North America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 124. Europe Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 125. Europe Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 126. Europe Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Biologics and Biosimilars Sales by Regions (2015-2020) (K Units)
Table 128. Asia-Pacific Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 131. South America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 132. South America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 135. Middle East & Africa Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 138. Global Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 139. Global Biologics and Biosimilars Sales Share by Type (2015-2020)
Table 140. Global Biologics and Biosimilars Revenue by Type (2015-2020) (USD Million)
Table 141. Global Biologics and Biosimilars Revenue Share by Type (2015-2020)
Table 142. Global Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 143. Global Biologics and Biosimilars Sales Share by Application (2015-2020)
Table 144. Global Biologics and Biosimilars Sales Forecast by Regions (2021-2025) (K Units)
Table 145. Global Biologics and Biosimilars Market Share Forecast by Regions (2021-2025)
Table 146. Global Biologics and Biosimilars Sales Forecast by Type (2021-2025) (K Units)
Table 147. Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025)
Table 148. Global Biologics and Biosimilars Sales Forecast by Application (2021-2025)
Table 149. Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biologics and Biosimilars Picture
Figure 2. Global Sales Market Share of Biologics and Biosimilars by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Interferon Picture
Figure 5. Erythropoietin Picture
Figure 6. Insulin Picture
Figure 7. Vaccines Picture
Figure 8. Other Picture
Figure 9. Biologics and Biosimilars Sales Market Share by Application in 2018
Figure 10. Tumor Picture
Figure 11. Diabetes Picture
Figure 12. Cardiovascular Picture
Figure 13. Hemophilia Picture
Figure 14. Other Picture
Figure 15. Global Biologics and Biosimilars Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2019
Figure 36. Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Biologics and Biosimilars Revenue Market Share by Regions (2015-2020)
Figure 43. Global Biologics and Biosimilars Revenue Market Share by Regions in 2018
Figure 44. North America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 45. Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 47. South America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 49. North America Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Figure 51. North America Biologics and Biosimilars Sales Market Share by Countries in 2018
Figure 52. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Biologics and Biosimilars Revenue Market Share by Countries in 2018
Figure 54. United States Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 60. Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Biologics and Biosimilars Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Biologics and Biosimilars Revenue Market Share by Regions 2019
Figure 68. China Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Biologics and Biosimilars Sales Market Share by Countries in 2019
Figure 75. South America Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 76. Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Biologics and Biosimilars Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Biologics and Biosimilars Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
Table 1. Global Biologics and Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biologics and Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Biologics and Biosimilars Major Business
Table 9. Roche Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 10. Roche SWOT Analysis
Table 11. Roche Biologics and Biosimilars Product and Services
Table 12. Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly Biologics and Biosimilars Major Business
Table 15. Eli Lilly Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 16. Eli Lilly SWOT Analysis
Table 17. Eli Lilly Biologics and Biosimilars Product and Services
Table 18. Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi-Aventis Biologics and Biosimilars Major Business
Table 21. Sanofi-Aventis Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 22. Sanofi-Aventis SWOT Analysis
Table 23. Sanofi-Aventis Biologics and Biosimilars Product and Services
Table 24. Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Amgen Basic Information, Manufacturing Base and Competitors
Table 26. Amgen Biologics and Biosimilars Major Business
Table 27. Amgen Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 28. Amgen SWOT Analysis
Table 29. Amgen Biologics and Biosimilars Product and Services
Table 30. Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 32. Novo Nordisk Biologics and Biosimilars Major Business
Table 33. Novo Nordisk Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 34. Novo Nordisk SWOT Analysis
Table 35. Novo Nordisk Biologics and Biosimilars Product and Services
Table 36. Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AbbVie Basic Information, Manufacturing Base and Competitors
Table 38. AbbVie Biologics and Biosimilars Major Business
Table 39. AbbVie Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 40. AbbVie SWOT Analysis
Table 41. AbbVie Biologics and Biosimilars Product and Services
Table 42. AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Biologics and Biosimilars Major Business
Table 45. Merck Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 46. Merck SWOT Analysis
Table 47. Merck Biologics and Biosimilars Product and Services
Table 48. Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Pfizer Basic Information, Manufacturing Base and Competitors
Table 50. Pfizer Biologics and Biosimilars Major Business
Table 51. Pfizer Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 52. Pfizer SWOT Analysis
Table 53. Pfizer Biologics and Biosimilars Product and Services
Table 54. Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 56. Johnson & Johnson Biologics and Biosimilars Major Business
Table 57. Johnson & Johnson Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 58. Johnson & Johnson SWOT Analysis
Table 59. Johnson & Johnson Biologics and Biosimilars Product and Services
Table 60. Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Biologics and Biosimilars Major Business
Table 63. Novartis Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 64. Novartis SWOT Analysis
Table 65. Novartis Biologics and Biosimilars Product and Services
Table 66. Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Gelgen Basic Information, Manufacturing Base and Competitors
Table 68. Gelgen Biologics and Biosimilars Major Business
Table 69. Gelgen Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 70. Gelgen SWOT Analysis
Table 71. Gelgen Biologics and Biosimilars Product and Services
Table 72. Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Ganlee Basic Information, Manufacturing Base and Competitors
Table 74. Ganlee Biologics and Biosimilars Major Business
Table 75. Ganlee Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 76. Ganlee SWOT Analysis
Table 77. Ganlee Biologics and Biosimilars Product and Services
Table 78. Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. 3sbio Basic Information, Manufacturing Base and Competitors
Table 80. 3sbio Biologics and Biosimilars Major Business
Table 81. 3sbio Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 82. 3sbio SWOT Analysis
Table 83. 3sbio Biologics and Biosimilars Product and Services
Table 84. 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Innovent Basic Information, Manufacturing Base and Competitors
Table 86. Innovent Biologics and Biosimilars Major Business
Table 87. Innovent Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 88. Innovent SWOT Analysis
Table 89. Innovent Biologics and Biosimilars Product and Services
Table 90. Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Biotech Biologics and Biosimilars Major Business
Table 93. Biotech Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 94. Biotech SWOT Analysis
Table 95. Biotech Biologics and Biosimilars Product and Services
Table 96. Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 98. Changchun High Tech Biologics and Biosimilars Major Business
Table 99. Changchun High Tech Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 100. Changchun High Tech SWOT Analysis
Table 101. Changchun High Tech Biologics and Biosimilars Product and Services
Table 102. Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Dong Bao Basic Information, Manufacturing Base and Competitors
Table 104. Dong Bao Biologics and Biosimilars Major Business
Table 105. Dong Bao Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 106. Dong Bao SWOT Analysis
Table 107. Dong Bao Biologics and Biosimilars Product and Services
Table 108. Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. CP Guojian Biologics and Biosimilars Type and Application
Table 110. CP Guojian Biologics and Biosimilars Major Business
Table 111. CP Guojian Biologics and Biosimilars Total Revenue (USD Million) (2017-2018)
Table 112. CP Guojian SWOT Analysis
Table 113. CP Guojian Biologics and Biosimilars Product and Services
Table 114. CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Biologics and Biosimilars Sales by Manufacturer (2018-2019) (K Units)
Table 116. Global Biologics and Biosimilars Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Biologics and Biosimilars Sales by Regions (2015-2020) (K Units)
Table 118. Global Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Table 119. Global Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 121. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 122. North America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 124. Europe Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 125. Europe Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 126. Europe Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Biologics and Biosimilars Sales by Regions (2015-2020) (K Units)
Table 128. Asia-Pacific Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 131. South America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 132. South America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 135. Middle East & Africa Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 138. Global Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 139. Global Biologics and Biosimilars Sales Share by Type (2015-2020)
Table 140. Global Biologics and Biosimilars Revenue by Type (2015-2020) (USD Million)
Table 141. Global Biologics and Biosimilars Revenue Share by Type (2015-2020)
Table 142. Global Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 143. Global Biologics and Biosimilars Sales Share by Application (2015-2020)
Table 144. Global Biologics and Biosimilars Sales Forecast by Regions (2021-2025) (K Units)
Table 145. Global Biologics and Biosimilars Market Share Forecast by Regions (2021-2025)
Table 146. Global Biologics and Biosimilars Sales Forecast by Type (2021-2025) (K Units)
Table 147. Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025)
Table 148. Global Biologics and Biosimilars Sales Forecast by Application (2021-2025)
Table 149. Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biologics and Biosimilars Picture
Figure 2. Global Sales Market Share of Biologics and Biosimilars by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Interferon Picture
Figure 5. Erythropoietin Picture
Figure 6. Insulin Picture
Figure 7. Vaccines Picture
Figure 8. Other Picture
Figure 9. Biologics and Biosimilars Sales Market Share by Application in 2018
Figure 10. Tumor Picture
Figure 11. Diabetes Picture
Figure 12. Cardiovascular Picture
Figure 13. Hemophilia Picture
Figure 14. Other Picture
Figure 15. Global Biologics and Biosimilars Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2019
Figure 36. Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Biologics and Biosimilars Revenue Market Share by Regions (2015-2020)
Figure 43. Global Biologics and Biosimilars Revenue Market Share by Regions in 2018
Figure 44. North America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 45. Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 47. South America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 49. North America Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Figure 51. North America Biologics and Biosimilars Sales Market Share by Countries in 2018
Figure 52. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Biologics and Biosimilars Revenue Market Share by Countries in 2018
Figure 54. United States Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 60. Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Biologics and Biosimilars Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Biologics and Biosimilars Revenue Market Share by Regions 2019
Figure 68. China Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Biologics and Biosimilars Sales Market Share by Countries in 2019
Figure 75. South America Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 76. Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Biologics and Biosimilars Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Biologics and Biosimilars Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
